Mobile Sensor Technologies to Assess General Symptomology of People With Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Centre Hospitalier Universitaire de Besancon
NantCell, Inc.
Virginia Commonwealth University
Elicio Therapeutics
Palleon Pharmaceuticals, Inc.
Novita Pharmaceuticals, Inc.
Hoffmann-La Roche
Instituto de Investigacion Sanitaria La Fe
Arbeitsgemeinschaft medikamentoese Tumortherapie
Intensity Therapeutics, Inc.
Cyprus University of Technology
Rutgers, The State University of New Jersey
Stanford University
Compugen Ltd
Washington University School of Medicine
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
VA Office of Research and Development
University of Southern California
UNC Lineberger Comprehensive Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of California, Davis
Memorial Sloan Kettering Cancer Center
Canadian Cancer Trials Group
Canadian Cancer Trials Group
Klus Pharma Inc.
Biologics & Biosimilars Collective Intelligence Consortium
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
SWOG Cancer Research Network
Genentech, Inc.
Roswell Park Cancer Institute
Kazakh Medical University of Continuing Education
Peter MacCallum Cancer Centre, Australia
Novartis
MacroGenics
Wake Forest University Health Sciences
Institut Bergonié
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)
Massachusetts General Hospital
University of Texas Southwestern Medical Center
Asana BioSciences
Abramson Cancer Center at Penn Medicine
Fox Chase Cancer Center
City of Hope Medical Center
University of Wisconsin, Madison